Cargando…

Angiopoietin‐2 and hemocompatibility‐related adverse events during percutaneous left ventricular assist device supports

Detalles Bibliográficos
Autores principales: Imamura, Teruhiko, Nakamura, Makiko, Yokoyama, Shigeki, Doi, Toshio, Fukahara, Kazuaki, Kinugawa, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714272/
https://www.ncbi.nlm.nih.gov/pubmed/33305013
http://dx.doi.org/10.1002/hsr2.211
_version_ 1783618719953453056
author Imamura, Teruhiko
Nakamura, Makiko
Yokoyama, Shigeki
Doi, Toshio
Fukahara, Kazuaki
Kinugawa, Koichiro
author_facet Imamura, Teruhiko
Nakamura, Makiko
Yokoyama, Shigeki
Doi, Toshio
Fukahara, Kazuaki
Kinugawa, Koichiro
author_sort Imamura, Teruhiko
collection PubMed
description
format Online
Article
Text
id pubmed-7714272
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77142722020-12-09 Angiopoietin‐2 and hemocompatibility‐related adverse events during percutaneous left ventricular assist device supports Imamura, Teruhiko Nakamura, Makiko Yokoyama, Shigeki Doi, Toshio Fukahara, Kazuaki Kinugawa, Koichiro Health Sci Rep Research Letter John Wiley and Sons Inc. 2020-12-03 /pmc/articles/PMC7714272/ /pubmed/33305013 http://dx.doi.org/10.1002/hsr2.211 Text en © 2020 The Authors. Health Science Reports published by Wiley Periodicals LLC. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Letter
Imamura, Teruhiko
Nakamura, Makiko
Yokoyama, Shigeki
Doi, Toshio
Fukahara, Kazuaki
Kinugawa, Koichiro
Angiopoietin‐2 and hemocompatibility‐related adverse events during percutaneous left ventricular assist device supports
title Angiopoietin‐2 and hemocompatibility‐related adverse events during percutaneous left ventricular assist device supports
title_full Angiopoietin‐2 and hemocompatibility‐related adverse events during percutaneous left ventricular assist device supports
title_fullStr Angiopoietin‐2 and hemocompatibility‐related adverse events during percutaneous left ventricular assist device supports
title_full_unstemmed Angiopoietin‐2 and hemocompatibility‐related adverse events during percutaneous left ventricular assist device supports
title_short Angiopoietin‐2 and hemocompatibility‐related adverse events during percutaneous left ventricular assist device supports
title_sort angiopoietin‐2 and hemocompatibility‐related adverse events during percutaneous left ventricular assist device supports
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714272/
https://www.ncbi.nlm.nih.gov/pubmed/33305013
http://dx.doi.org/10.1002/hsr2.211
work_keys_str_mv AT imamurateruhiko angiopoietin2andhemocompatibilityrelatedadverseeventsduringpercutaneousleftventricularassistdevicesupports
AT nakamuramakiko angiopoietin2andhemocompatibilityrelatedadverseeventsduringpercutaneousleftventricularassistdevicesupports
AT yokoyamashigeki angiopoietin2andhemocompatibilityrelatedadverseeventsduringpercutaneousleftventricularassistdevicesupports
AT doitoshio angiopoietin2andhemocompatibilityrelatedadverseeventsduringpercutaneousleftventricularassistdevicesupports
AT fukaharakazuaki angiopoietin2andhemocompatibilityrelatedadverseeventsduringpercutaneousleftventricularassistdevicesupports
AT kinugawakoichiro angiopoietin2andhemocompatibilityrelatedadverseeventsduringpercutaneousleftventricularassistdevicesupports